BioBanking - The Holy Grail of novel drug and diagnostic developmentsReport as inadecuate




BioBanking - The Holy Grail of novel drug and diagnostic developments - Download this document for free, or read online. Document in PDF available to download.

Journal of Clinical Bioinformatics

, 1:14

First Online: 13 May 2011Received: 02 March 2011Accepted: 13 May 2011DOI: 10.1186-2043-9113-1-14

Cite this article as: Marko-Varga, G. J Clin Bioinform 2011 1: 14. doi:10.1186-2043-9113-1-14

Abstract

The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.

List of abbreviationsHPPHuman Proteome Project

Electronic supplementary materialThe online version of this article doi:10.1186-2043-9113-1-14 contains supplementary material, which is available to authorized users.

Download fulltext PDF



Author: György Marko-Varga

Source: https://link.springer.com/







Related documents